Product Information
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP is a generic product labeled by Sandoz Inc., priced at $0.1181 per EA under NDC 00781207401. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 5, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 37.5 mg/1; mg/1
Manufacturer
Sandoz Inc.NDC
00781207401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; TRIAMTERENEApproval Type
Generic (ANDA)
FDA Application
ANDA074821FDA Approved
6/5/1997
TE Code
AB
On Market Since
6/5/1997
Pharmacological Classes
Price Statistics
The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1181 per EA |
|---|---|
| All-time high | $0.1983 (Feb 10, 2016) |
| All-time low | $0.0844 (Jul 17, 2024) |
| 52-week high | $0.1221 |
| 52-week low | $0.1128 |
| Median price | $0.1362 |
| Average price | $0.1413 |
| Largest weekly change | +46.0% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Triamterene and Hydrochlorothiazide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Potassium-sparing Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP, manufactured by Sandoz Inc., is $0.1181 per EA (NDC 00781207401), effective Sep 30, 2026.
How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP changed over time?
Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP has declined 34.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?
Since Nov 28, 2013, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP has ranged from a low of $0.0844 (Jul 17, 2024) to a high of $0.1983 (Feb 10, 2016), with a median of $0.1362 per EA.
Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP (NDC 00781207401) is labeled by Sandoz Inc., and CMS classifies it as a generic product.